Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Velo3D (VLDXW) Shares Outstanding (Weighted Average) (2020 - 2025)

Velo3D has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $16.5 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 1845.89% year-over-year to $16.5 million; the TTM value through Dec 2025 reached $16.5 million, up 1845.89%, while the annual FY2025 figure was $16.5 million, 1845.89% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $16.5 million at Velo3D, down from $17.1 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $201.0 million in Q1 2025 and troughed at $565026.0 in Q2 2024.
  • A 5-year average of $59.4 million and a median of $16.2 million in 2021 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): tumbled 96.95% in 2023 and later soared 2679.79% in 2025.
  • Year by year, Shares Outstanding (Weighted Average) stood at $58.7 million in 2021, then skyrocketed by 215.36% to $185.1 million in 2022, then tumbled by 96.95% to $5.6 million in 2023, then plummeted by 84.97% to $847265.0 in 2024, then skyrocketed by 1845.89% to $16.5 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for VLDXW at $16.5 million in Q4 2025, $17.1 million in Q3 2025, and $13.7 million in Q2 2025.